These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34923245)

  • 21. Molecular characterisation of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province, China.
    Wu SY; Lei Y; Kang M; Xiao YL; Chen ZX
    Mycoses; 2015 May; 58(5):280-7. PubMed ID: 25808662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting.
    Olivares LR; Martínez KM; Cruz RM; Rivera MA; Meyer W; Espinosa RA; Martínez RL; Santos GM
    Med Mycol; 2009 Nov; 47(7):713-21. PubMed ID: 19888804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
    Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
    mBio; 2012; 3(3):. PubMed ID: 22570277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
    Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
    Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Native trees of the Northeast Argentine: natural hosts of the Cryptococcus neoformans-Cryptococcus gattii species complex.
    Cattana ME; Sosa Mde L; Fernández M; Rojas F; Mangiaterra M; Giusiano G
    Rev Iberoam Micol; 2014; 31(3):188-92. PubMed ID: 23810786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in nitrogen metabolism between Cryptococcus neoformans and C. gattii, the two etiologic agents of cryptococcosis.
    Ngamskulrungroj P; Chang Y; Roh J; Kwon-Chung KJ
    PLoS One; 2012; 7(3):e34258. PubMed ID: 22479580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk.
    Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM
    Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of combination of Cryptococcus gattii and IFN-γ, IL-4 or IL-27 on human bronchial epithelial cells.
    Cunha MM; Pereira ABM; Lino RC; da Silva PR; Andrade-Silva LE; de Vito FB; de Souza HM; Silva-Vergara ML; Rogério AP
    Immunobiology; 2023 Jan; 228(1):152312. PubMed ID: 36577248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
    Feng X; Yao Z; Ren D; Liao W; Wu J
    FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multilocus Sequence Typing of Clinical Isolates of Cryptococcus from India.
    Xess I; Pandey M; Dabas Y; Agarwal R; Das S; Srivastava PMV; Thakur R; Sharma S; Mani P; Biswas A; Bhowmik D; Das BK; Singh R; Panda P; Singh G; Phukan AC; Yhome M; Valsan C; Kindo AJ
    Mycopathologia; 2021 May; 186(2):199-211. PubMed ID: 33469844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genotyping of Cryptococcus neoformans/Cryptococcus gattii complex clinical isolates from Hospital "Dr. Julio C. Perrando", Resistencia city (Chaco, Argentina)].
    Cattana ME; Tracogna MF; Fernández MS; Carol Rey MC; Sosa MA; Giusiano GE
    Rev Argent Microbiol; 2013; 45(2):89-92. PubMed ID: 23876270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species Complex.
    Aminnejad M; Cogliati M; Duan S; Arabatzis M; Tintelnot K; Castañeda E; Lazéra M; Velegraki A; Ellis D; Sorrell TC; Meyer W
    PLoS One; 2016; 11(10):e0163955. PubMed ID: 27764108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii.
    Firacative C; Duan S; Meyer W
    PLoS One; 2014; 9(8):e105076. PubMed ID: 25133687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
    Nyazika TK; Hagen F; Meis JF; Robertson VJ
    J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.
    Hurtado JC; Castillo P; Fernandes F; Navarro M; Lovane L; Casas I; Quintó L; Marco F; Jordao D; Ismail MR; Lorenzoni C; Martinez-Palhares AE; Ferreira L; Lacerda M; Monteiro W; Sanz A; Letang E; Marimon L; Jesri S; Cossa A; Mandomando I; Vila J; Bassat Q; Ordi J; Menéndez C; Carrilho C; Martínez MJ
    Sci Rep; 2019 May; 9(1):7493. PubMed ID: 31097746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.